TEOSYAL®

About TEOSYAL® and RHA® Technology

Crafted by Teoxane Laboratories in Geneva, Switzerland, TEOSYAL® relies on its core innovation known as RHA®, which stands for Resilient Hyaluronic Acid. This specialized crosslinked HA gel is engineered to compress under facial muscle strain and rapidly rebound to its original form instead of pushing back against natural expressions.

This adaptability forms the core of its engineering. Traditional HA dermal fillers frequently feel and appear rigid in high-movement zones such as the mouth and jawline, primarily because their stiffness fails to match nearby biological tissue. Teoxane engineered RHA® alongside dermatologists to eliminate this mismatch, producing a product that mimics natural tissue dynamics instead of opposing them. Consequently, it stands among the select few hyaluronic acid filler innovations formulated alongside skin specialists precisely for areas of constant movement.

Alongside RHA®, TEOSYAL® runs a second product family called PURESENSE. This is essentially the lidocaine-containing version of most products in the range, there to make the TEOSYAL® injection more comfortable without changing the underlying gel technology itself. In the US market, the FDA-approved RHA® Collection integrates lidocaine or mepivacaine directly into its formulations, whereas the European PURESENSE line maintains separate branding for its anesthetic-containing versions. [4]

TEOSYAL® PURESENSE Range

• Formulated with lidocaine, TEOSYAL® PURESENSE DEEP LINES focuses directly on stubborn folds and severe wrinkles, such as nasolabial lines.
• TEOSYAL® PURESENSE GLOBAL ACTION serves as a versatile, multi-zone rejuvenation treatment containing lidocaine, designed to address minor volume deficits and superficial lines across multiple facial regions simultaneously.
• TEOSYAL® PURESENSE KISS is specifically engineered for the lips with added lidocaine, providing hydration, fullness, and enhanced contouring, making it among the brand’s most sought-after dermal fillers.
• TEOSYAL® PURESENSE REDENSITY I (1x3ml) functions as a biorevitalization skin booster supplied in a single 3 ml volume to cover wider zones, such as improving periorbital skin texture.
• TEOSYAL® PURESENSE REDENSITY I (2x1ml) utilizes the identical gel composition divided into a pair of 1 ml syringes, offering clinicians greater versatility between appointments.
• TEOSYAL® PURESENSE REDENSITY II (2x1ml) is tailored exclusively for the tear trough and periocular region, targeting shadows and hollowness in this sensitive zone.
• TEOSYAL® PURESENSE ULTIMATE (2x1ml) delivers high-density volumization with integrated lidocaine, crafted for areas like the jawline, chin, and cheeks that require robust structural reinforcement.
• TEOSYAL® PURESENSE ULTRA DEEP (2x1ml) represents the collection’s highest-density option, engineered for deep structural rebuilding and maximum-level facial contouring.

TEOSYAL® RHA® Range

• TEOSYAL® RHA KISS with Lidocaine is the RHA® family’s dedicated lip filler, pairing natural flexibility during facial movements with lidocaine for a more comfortable injection experience. This product is available in CE-marked regions (Europe, UK, Canada) as a distinct 0.7 ml syringe. It is not sold under this name in the US market.
• TEOSYAL® RHA1 has the lowest viscosity in the RHA® line and is best suited to superficial fine lines and more delicate treatment areas. In the US, RHA1 is FDA-approved for dynamic perioral rhytids. [4]
• TEOSYAL® RHA2 sits in the middle of the range. It handles moderate lines and folds and is versatile enough for multi-area treatment across the face.
• TEOSYAL® RHA3 (2x1ml) steps up in viscosity, suited to deeper wrinkles, nasolabial folds, and cheek work, and comes packaged as two 1 ml syringes. RHA3 has also been studied for lip augmentation. [3]
• TEOSYAL® RHA4 is the highest viscosity product in the RHA® range, built for deep facial contours, cheek augmentation, and maximum lift where it’s genuinely needed.

Full TEOSYAL® Product Range – Buy TEOSYAL® Wholesale

Teoxane’s broader range of dermal fillers under the TEOSYAL® name includes several additional presentations.

• TEOSYAL® KISS (original, no lidocaine), the non-anesthetic version of the lip filler, available in CE-marked regions
• TEOSYAL® DEEP LINES (no lidocaine)
• TEOSYAL® GLOBAL ACTION (no lidocaine)
• TEOSYAL® MESO, a mesotherapy-grade HA product for skin hydration
• TEOSYAL® REDENSITY [1] and REDENSITY [2], the no-lidocaine versions of the skin booster and tear trough products
• TEOSYAL® ULTIMATE and ULTRA DEEP (no lidocaine)
• TEOSYAL® RHA Redensity, an RHA® product FDA-approved in the US for moderate to severe dynamic perioral rhytids [4]
• TEOSYAL® RHA Dynamic Volume, a newer addition to the RHA® line with FDA approval for cheek augmentation and correction of age-related midface contour loss [1]

Treatment Areas and Clinical Indications

When it comes to lip enhancement, both PURESENSE KISS and RHA KISS function as TEOSYAL® lip fillers designed to provide volume and moisture, though RHA KISS stands out by adapting to the mouth’s natural movements. While RHA KISS is sold as an independent brand in CE-marked territories, American clinicians generally rely on alternative RHA® formulations for lips pursuant to FDA guidelines. This difference is more significant than it appears initially, since the lips are rarely still, and a product lacking flexibility becomes apparent much sooner.

To address cheeks and wider facial architecture, RHA3, RHA4, PURESENSE ULTIMATE, and PURESENSE ULTRA DEEP manage a spectrum of needs, ranging from mild deflation to heavy structural rebuilding in the midface and cheek zones. Additionally, RHA Dynamic Volume provides an FDA-cleared choice tailored explicitly for cheek enhancement.

Regarding the delicate under-eye region, PURESENSE REDENSITY II serves as the specialized tear trough solution, engineered precisely for hollows and shadowing instead of a generic TEOSYAL® formula forced to work in a fragile area.

For overall skin health and moisture levels, PURESENSE REDENSITY I functions as a TEOSYAL® skin booster, prioritizing biorevitalization over dimensional filling.

To smooth out minor lines and creases, options like RHA1, RHA2, PURESENSE DEEP LINES, and PURESENSE GLOBAL ACTION diminish wrinkles cleanly while avoiding excessive fullness. Furthermore, RHA1 and RHA Redensity hold specific FDA clearances in the United States for treating dynamic perioral rhytids. [4]

Is TEOSYAL® FDA Approved? Why Practitioners Buy TEOSYAL® Wholesale

In the United States, Teoxane partners with Revance Therapeutics to distribute the FDA-approved RHA® Collection. The following products carry individual FDA approvals:

• RHA1: dynamic perioral rhytids and lines
• RHA2 and RHA4: moderate to severe dynamic facial wrinkles and folds, including nasolabial folds, in adults 22 and older
• RHA3: moderate to severe dynamic facial wrinkles and folds. RHA3 has also been studied for lip augmentation in clinical trials. [3]
• RHA Redensity: moderate to severe dynamic perioral rhytids [4]
• RHA Dynamic Volume: cheek augmentation and correction of age-related midface contour deficiencies [1][2]

These FDA approvals apply specifically to the RHA® Collection, not to the broader TEOSYAL® catalog. The PURESENSE range and the non-RHA TEOSYAL® classic line are CE-marked for European and international markets but do not carry individual US FDA approvals. Practitioners ordering for use in the United States should verify the specific TEOSYAL® FDA approval status of whatever they plan to use before treatment.

Duration and Reversibility

How long the results last relies greatly on the specific product used and the zone being treated. Formulas like RHA2, RHA3, and RHA4 typically hold up for a full year up to 15 months. In contrast, RHA KISS and RHA1 have a briefer lifespan of roughly half a year to nine months, largely reflecting the constant muscle activity in those regions. PURESENSE ULTIMATE maintains its effects for 12 to 18 months because of its thick consistency and deep injection placement.

For the delicate under-eye zone, REDENSITY II usually stays visible for nine months to a year, whereas REDENSITY I functions as a skin booster requiring touch-ups around the six-month mark.

All TEOSYAL® dermal fillers are formulated with hyaluronic acid and can be completely dissolved using hyaluronidase should any adjustments be necessary.

Benefits, Safety, and Side Effects

One of the main advantages of the TEOSYAL® RHA® filler technology is its ability to adapt to natural facial movement. Unlike more rigid cross-linked HA formulations, RHA® fillers are designed to maintain flexibility in dynamic areas such as the lips, nasolabial folds, and lower face. This can translate to lower palpability and reduced displacement risk when the filler is appropriately selected and placed. TEOSYAL® before-and-after results are typically visible immediately, with final outcomes settling over two to four weeks as initial swelling resolves. TEOSYAL® dermal filler reviews from practitioners tend to highlight the natural feel of RHA® products in dynamic treatment areas in particular.

The most common side effects of TEOSYAL® are generally mild and temporary. These may include bruising, swelling, redness, tenderness, and mild discomfort at the injection site. Less common potential side effects of TEOSYAL® can include nodules, asymmetry, prolonged swelling, or vascular occlusion. As with other hyaluronic acid (HA) fillers, many of these risks are closely related to injection technique, anatomical knowledge, patient selection, and correct product placement.

Because every TEOSYAL® dermal filler is hyaluronic acid-based, the product can be dissolved with hyaluronidase when clinically indicated. Practitioners should still follow appropriate consent, injection, and post-treatment protocols and remain prepared to identify and manage potential complications promptly.

TEOSYAL® Compared to Other HA Fillers

Practitioners looking to buy TEOSYAL® filler may want to compare its RHA® technology, indications, and regulatory profile with other established HA filler ranges.

vs Restylane®

Both TEOSYAL® RHA® and Restylane® XpresHAn Technology™ are designed for dynamic facial areas, making this the most direct technology comparison among current HA filler platforms. For the under-eye area, Restylane® EYELIGHT™ and TEOSYAL® PURESENSE REDENSITY II compete head-to-head, and REDENSITY II is one of the most clinically studied European tear trough fillers in the published literature. [5]

The Restylane® portfolio holds a broader set of FDA approvals, including LYFT, KYSSE, DEFYNE, and REFYNE across multiple facial zones.

vs JUVÉDERM®

JUVÉDERM® uses VYCROSS® to create smooth, cohesive monophasic gels favored for mid-face longevity, with some VYCROSS® products lasting 18 to 24 months. TEOSYAL® differentiates through RHA® technology, which prioritizes flexibility with facial movement over raw longevity. For lips specifically, JUVÉDERM® Volbella and Ultra Smile compete with TEOSYAL® KISS and RHA KISS. Both lip options are well-validated, though RHA KISS offers expression-area flexibility that VYCROSS® formulations do not specifically target. JUVÉDERM® holds a broader FDA indication set in the US overall.

vs STYLAGE®

STYLAGE® uses IPN-Like cross-linking that incorporates mannitol, an antioxidant intended to reduce post-injection edema and extend HA longevity by neutralizing free radicals in the treated tissue. There is no RHA®-equivalent dynamic technology in the STYLAGE® range. For lip filler specifically, STYLAGE® Special Lips and TEOSYAL® KISS both carry CE marking, though no head-to-head randomized controlled trial establishes a clear advantage for either product. TEOSYAL® has a stronger FDA presence, while STYLAGE® remains more established in European markets.

vs BELOTERO®

BELOTERO® uses Cohesive Polydensified Matrix (CPM) technology for even tissue integration, and it is widely considered best-in-class for superficial fine lines where Tyndall effect risk must be minimized. TEOSYAL® RHA1 and PURESENSE DEEP LINES target similar indications through a different mechanism. For deeper volumizing and dynamic areas, BELOTERO® Intense and Volume are the deepest products in that range but are not RHA-engineered. There is also no dedicated BELOTERO® tear trough product to match REDENSITY II.

vs REVANESSE®

REVANESSE® differentiates primarily on tolerability, with relatively low post-treatment swelling compared to some competitors. REVANESSE® LIPS+ directly competes with TEOSYAL® KISS in the lip segment. Beyond lips, however, REVANESSE® offers a smaller product range with no dedicated tear trough filler, no skin booster equivalent, and no dynamic movement-specific technology comparable to RHA®. It is competitively priced against TEOSYAL® in wholesale channels.

Where to Buy TEOSYAL® Online at Wholesale Prices?

Doctor Medica is a trusted wholesale platform for licensed aesthetic practitioners who want to buy TEOSYAL® wholesale without the usual sourcing headaches. We run a price-beat program, offer free shipping on orders over $1,000, and back every order with a 14-day delivery guarantee that’s often beaten by a wide margin across the USA, plus temperature-controlled shipping for products that need it.

For practitioners evaluating TEOSYAL® cost across distributors, our wholesale pricing scales with volume, and we’ve built the platform so that comparing TEOSYAL® price per unit is straightforward regardless of how many SKUs you’re ordering.

Licensed practitioners can purchase TEOSYAL® online through a fast 24-hour license verification process, with no minimum order required. If you’d prefer to order TEOSYAL® online rather than call in, the same verification and ordering process applies either way.

Whether you’re looking to buy TEOSYAL® products individually or stock a full range refresh, every order ships with authentic product backed by verifiable LOT numbers, a dedicated account manager, and fully tracked international fulfillment from order to delivery.

Frequently Asked Questions

What is TEOSYAL®?

TEOSYAL® is a hyaluronic acid filler range by Teoxane Laboratories in Geneva, Switzerland, covering fine lines, dynamic wrinkles, lip enhancement, under-eye correction, facial volumizing, and skin revitalization through its RHA® and PURESENSE product families.

What is TEOSYAL® RHA® Technology?

RHA® stands for Resilient Hyaluronic Acid, a cross-linked HA technology designed to adapt to facial movement while maintaining gel integrity, making it particularly suited to dynamic treatment areas.

Is TEOSYAL® FDA approved?

The RHA® Collection (RHA1, RHA2, RHA3, RHA4, RHA Redensity, and RHA Dynamic Volume) is FDA-approved in the US, distributed through Revance Therapeutics. The broader PURESENSE and classic TEOSYAL® lines are CE-marked for international markets but do not carry individual US FDA approvals.

How long does TEOSYAL® filler last?

Results vary by product and treatment area. RHA2, 3, and 4 may last 12 to 15 months, while RHA KISS and RHA1 typically last 6 to 9 months, and longer-lasting volumizing products may provide results for up to 18 months.

What is TEOSYAL® REDENSITY II used for?

REDENSITY II is a dedicated tear trough and under-eye filler with a soft thixotropic gel formulated specifically for the delicate periorbital area, where it helps correct hollowness and dark circles.

Is TEOSYAL® a good filler?

Teoxane is a Swiss pharmaceutical-standard manufacturer, and RHA® is one of the few HA filler technologies developed with dermatologists specifically for dynamic expression areas, validated across multiple randomized controlled trials.

JUVÉDERM® vs TEOSYAL®: which is better?

The answer is indication-dependent. JUVÉDERM® VYCROSS® products tend to lead in mid-face longevity, while TEOSYAL® RHA® has a specific advantage in dynamic expression areas where flexibility during facial movements matters most.

Where can practitioners buy TEOSYAL® wholesale?

Licensed practitioners can buy TEOSYAL® wholesale through Doctor Medica, with LOT-verified products, competitive pricing, free shipping on qualifying orders over $1,000, and dedicated account support.

For licensed medical professionals only. This content is for informational purposes only and does not constitute medical advice.

Citations and Resources

[1] Revance. “Revance and Teoxane Announce the FDA Approval of RHA® Dynamic Volume for Midface Contour Deficiencies.” PR Newswire, 13 Jan. 2026, www.prnewswire.com/news-releases/revance-and-teoxane-announce-the-fda-approval-of-rha-dynamic-volume-for-midface-contour-deficiencies-302658756.html.

[2] Teoxane. “Pioneering a Safer, More Advanced Aesthetic Medicine.” Teoxane, http://www.teoxane.com/en/about-teoxane/milestones.

[3] Weinkle, Susan et al. “Effectiveness and Safety of RHA3 vs a Comparator Product for Lip Augmentation: A Randomized, Controlled, Prospective, Multicenter Clinical Study.” Aesthetic surgery journal vol. 45,11 (2025): 1175-1186. doi:10.1093/asj/sjaf135

[4] Revance. “Revance Launches the Teoxane RHA® Collection with Mepivacaine.” Revance, 27 Aug. 2025, www.revance.com/news/press-releases/teoxane-rha-collection-mepivacaine-launch.

[5] Teoxane SA. A Randomized, Blinded Evaluator, No-Treatment Control, Multicenter, Prospective Clinical Study of RHA® 1 for the Treatment of Moderate to Severe Tissue Volume Deficiencies in the Infraorbital Regions. Clinical Investigation Plan TEO-RHA-1902, version 12.0, 24 Apr. 2024. ClinicalTrials.gov.

Written by Doctor Medica’s Editorial team

The content on this page has been written and fact-checked in accordance with our Editorial Policy. Clinical claims are sourced from peer-reviewed literature, regulatory documentation, and manufacturer specifications. Where citations are provided, it is always in accordance to our editorial standards.

Doctor Medica sources products exclusively through authorized distributors and established procurement channels. Products are verified as genuine, and supplied in the original packaging with their seal intact. Learn more about how we guarantee product authenticity, sourcing compliance, and traceable delivery to our clients.